Adjunct Diagnostic Accuracy of Antigen-specific Interleukin-2 for Latent Tuberculosis Infection in Pregnancy
Open Access
- 25 April 2026
- journal article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (5)
Abstract
Background: Pregnancy modulates immune responses against Mycobacterium tuberculosis (Mtb) infection. Cytokines, including interleukin-2 (IL-2), play a crucial role in Mtb containment, mainly by inducing the proliferation of T cells. However, the role of IL-2 in latent tuberculosis (TB) infection (LTBI) screening has not been completely explored. We, therefore, evaluated the diagnostic accuracy and optimal cutoff value (OCV) of IL-2 as a potential adjunct biomarker for screening LTBI during pregnancy. Methods: We enrolled pregnant women without previous active TB at Kawempe National Referral Hospital, Uganda, in 2020. We tested for LTBI using the QuantiFERON-TB Gold-Plus assay. Blood in quantiFERON blood collection tubes was stimulated with Mtb peptides of ESAT-6 and CFP-10 and following incubation, IL-2 culture supernatant levels were measured in an 11-plex Luminex assay using the Luminex® 100/200™ System with xPONENT® 3.1 software. LTBI positivity was defined as an IFN-γ concentration ≥0.35 IU/mL (calculated as TB1/TB2-Nil). A receiver operator characteristic curve was plotted to assess the diagnostic performance of Mtb-specific IL-2 culture supernatants using STATA 18.0. The OCV was determined using the Youden index, considering sensitivity and specificity. Results: Of 159 participants, the median gestational age was 26.1 (IQR: 20.0–31.6) weeks, 8.2% (n = 13) had HIV, and 10.1% (n = 16) were recent TB contacts. Overall, 79 (49.7%) had LTBI. Mtb-specific IL-2 levels were significantly higher in LTBI than in the non-LTBI group (847.9 (418.2–1309.1) versus 147.73 (100.38–207.19) pg/mL, P < .001). IL-2 achieved an AUC of 0.88 (95% CI: 0.82–0.93), with 76% sensitivity and 96% specificity. IFN-γ showed an AUC of 0.83 (95% CI: 0.76–0.90), with 78% sensitivity and 90% specificity. The combined IL-2 + IFN-γ response yielded the highest accuracy, with an AUC of 0.89 (95% CI: 0.83–0.94), 77% sensitivity, and 95% specificity. Conclusions: Mtb-specific IL-2 culture supernatant levels showed good discriminatory power for LTBI detection in pregnancy, comparable to IFN-γ, with the combined IL-2+ IFN-γ response yielding the highest accuracy. These findings support the potential utility of IL-2, alone or with IFN-γ, as an adjunct biomarker for LTBI screening in pregnant women, warranting further validation in larger, diverse cohorts.Keywords
Funding Information
- Crick African Network
- Global Challenges Research Fund
- Fogarty International Center
This publication has 35 references indexed in Scilit:
- Preventive therapy for latent tuberculosis infection—the promise and the challengesInternational Journal of Infectious Diseases, 2017
- Cytokine Patterns in Tuberculosis Infection; IL-1ra, IL-2 and IP-10 Differentiate Borderline QuantiFERON-TB Samples from Uninfected ControlsPLOS ONE, 2016
- Latent Tuberculosis in Pregnancy: A Systematic ReviewPLOS ONE, 2016
- First independent evaluation of QuantiFERON-TB Plus performanceEuropean Respiratory Journal, 2016
- Prevalence and risk factors of latent Tuberculosis among adolescents in rural Eastern UgandaAfrican Health Sciences, 2015
- Novel T-Cell Assays for the Discrimination of Active and Latent Tuberculosis Infection: The Diagnostic Value of PPE FamilyMolecular Diagnosis & Therapy, 2015
- Tuberculosis in pregnancy: an estimate of the global burden of diseaseThe Lancet Global Health, 2014
- Evaluation of the Diagnostic Potential of IP-10 and IL-2 as Biomarkers for the Diagnosis of Active and Latent Tuberculosis in a BCG-Vaccinated PopulationPLOS ONE, 2012
- Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsiaClinical and Experimental Immunology, 1999
- Shifts in the TH1/TH2 Balance during Human Pregnancy Correlate with Apoptotic ChangesBiochemical and Biophysical Research Communications, 1998